Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that Mark Rothera, President and Chief Executive Officer, and Darrel P. Cohen, M.D., Ph.D., Chief Medical Officer, are scheduled to participate in a fireside chat at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 11:00 a.m. EDT.
聖地亞哥，2024年5月7日（GLOBE NEWSWIRE）——專注於治療和預防影響全球患者的病毒相關癌症的臨床階段精準腫瘤學公司Viracta Therapeutics, Inc.（納斯達克股票代碼：VIRX）今天宣佈，總裁兼首席執行官馬克·羅瑟拉和首席醫學官達雷爾·科恩醫學博士，計劃參加爐邊活動美國東部時間2024年5月14日星期二上午11點，在加拿大皇家銀行資本市場全球醫療保健會議上聊天。
A live webcast of the presentation will be available on the Investors section of the Viracta website under "Events and Webcasts" and archived for 90 days.
該演講的網絡直播將在Viracta網站的 “投資者” 部分的 “活動和網絡直播” 下提供，並存檔90天。
譯文內容由第三人軟體翻譯。